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Safety of lumbar puncture in comatose
children with clinical features of cerebral
malaria
ABSTRACT
Objective: We assessed the independent association of lumbar puncture (LP) and death in Mala-
wian children admitted to the hospital with the clinical features of cerebral malaria (CM).
Methods: This was a retrospective cohort study in Malawian children with clinical features of CM.
Allocation to LP was nonrandom and was associated with severity of illness. Propensity score–
based analyses were used to adjust for this bias and assess the independent association between
LP and mortality.
Results: Data were available for 1,075 children: 866 (80.6%) underwent LP and 209 (19.4%) did
not. Unadjusted mortality rates were lower in children who underwent LP (15.3% vs 26.7% in the
no-LP group) but differences in covariates between the 2 groups suggested bias in LP allocation.
After propensity score matching, all covariates were balanced. Propensity score–based analyses
showed no change in mortality rate associated with LP: by inverse probability weighting, the
average risk reduction was 2.0% at 12 hours (95% confidence interval 21.5% to 5.5%, p 5
0.27) and 1.7% during hospital admission (95% confidence interval24.5% to 7.9%, p5 0.60).
Undergoing LP did not change the risk of mortality in subanalyses of children with severe brain
swelling on MRI or in those with papilledema.
Conclusion: In comatose children with suspected CM who were clinically stable, we found no evi-
dence that LP increases mortality, even in children with objective signs of raised intracranial
pressure. Neurology® 2016;87:2355–2362
GLOSSARY
CI 5 confidence interval; CM 5 cerebral malaria; ICP 5 intracranial pressure; LP 5 lumbar puncture.
Cerebral malaria (CM)—defined as coma, Plasmodium falciparum parasitemia, and the exclu-
sion of other causes of encephalopathy—is a leading cause of death in sub-Saharan Africa.1,2
CNS coinfections are well recognized in these patients,3 and can only be reliably excluded by
lumbar puncture (LP).
Despite its diagnostic utility, performing LPs in children with suspected CM is controversial
because the disease may cause raised intracranial pressure (ICP).2 Brain swelling has recently
been shown to be an independent predictor of death in CM.4 Some physicians are concerned
that LP in the context of diffusely increased ICP may precipitate fatal herniation2,5,6; others
believe the procedure is safe in the absence of overt brain shift.7,8
Executing a randomized clinical trial to determine if LP is associated with death in children
with CM would be problematic. Instead, we carried out a retrospective analysis of children with
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clinical features of CM in whom LPs were per-
formed unless there were asymmetrical neuro-
logic findings or the admitting clinician
believed the child was medically unstable.
To adjust for the selection bias against chil-
dren who were more severely ill and thus had
a higher chance of a fatal outcome, we used
propensity score–based analyses.9 The pro-
pensity score represents the probability, based
on observed clinical characteristics, that a par-
ticipant received the intervention—in this
case, an LP. Matching children by propensity
score controls for illness severity, in effect
simulating a clinical trial. We used this
approach to assess the association between LP
and death within 12 hours of admission and
during the entire hospitalization.
METHODS We studied comatose (Blantyre Coma Score #2)
children aged 6 months to 16 years, admitted to a study investi-
gating CM pathogenesis on the Pediatric Research Ward, Queen
Elizabeth Central Hospital, Blantyre, Malawi, from January 1997
to June 2013.
Children with neck stiffness had an LP performed prior to
research ward admission. Those with visibly cloudy CSF were
enrolled in studies on meningitis treatment, were not enrolled
in the parent study, and are not included here. Children discov-
ered to have meningitis after research ward admission were
included.
LPs were performed using 21-gauge needles in children deemed
medically stable by the admitting clinician, following informed
parental consent. LPs were performed either before research ward
admission (in the emergency department or general pediatric ward)
or on the research ward within 30 minutes of admission. Twelve-
hour mortality was determined from the time of LP (in those
who underwent LP) or from the time of research ward admission
(in those who did not undergo LP). Children had a funduscopic
examination by the admitting clinician and if papilledema was sus-
pected, an LP was not performed. Following admission investiga-
tions, including LP, definitive funduscopic examination was
performed by an ophthalmologist; the ophthalmologist’s determi-
nation of the presence or absence of papilledema was used in our
analyses. LPs were done in children with papilledema when it was
recognized by the ophthalmologist after LP performance.10 The
ophthalmologist’s funduscopic examination also assessed for char-
acteristic retinal changes that are a sensitive and specific indicator of
the presence of sequestered malaria-infected erythrocytes in the
brain.11 This assessment distinguishes children with retinopathy-
positive CM from those with retinopathy-negative CM, who are
more likely to have a nonmalarial cause of coma.11
Parasitemic patients were treated with IV quinine. Adjunctive
ceftriaxone was given until clinical recovery to all children in
whom an LP was omitted. Among children who received an LP,
aparasitemic children and children with retinopathy-negative
CM were given empirical ceftriaxone pending blood cultures,
whereas children with retinopathy-positive CM were only given
ceftriaxone if there was significant CSF pleocytosis (leukocytes
.30/mL), signs of sepsis, or fever following parasite clearance.
Beginning in 2009, after LP, children who were clinically sta-
ble underwent brain MRI with a 0.35T Signa Ovation Excite
scanner (GE Healthcare, Milwaukee, WI) within 12 hours of
admission. MRI scans were independently interpreted by 2
radiologists.12
Study protocol approvals, registrations, and patient
consents. The parent study’s protocol was approved by the Uni-
versity of Malawi College of Medicine Research Ethics Commit-
tee and the Biomedical Institutional Review Board of Michigan
State University.
Statistical analysis. Propensity score calculations included char-
acteristics likely to influence a clinician’s decision to perform an
LP and those previously established as being associated with fatal
outcome, including the following:
1. Depth of coma (Blantyre Coma Score)
2. Systolic blood pressure for age
3. Weight-for-height z score (nutritional status)
4. Respiratory distress or acidotic breathing
5. Pulse rate
6. Cardiovascular system examination (signs of heart failure)
7. Sex
8. Admission blood glucose concentration
9. Peripheral parasite density
10. Hematocrit
11. Malarial retinopathy status
12. Papilledema
The various propensity score–based analysis methods each
have strengths and weaknesses. To ensure methodologic rigor, we
used 3 methods to assess the independent association of LP with
mortality: (1) inverse probability weighting, (2) unconditional
logistic regression where propensity score was an independent
variable, and (3) nearest neighbor propensity score matching
(with replacement).13 We imputed retinopathy status in 456
participants in whom this variable was missing using logistic
regression based on predictive characteristics: platelet count,
hematocrit, and glucose.14 In participants where the calculated
likelihood of being retinopathy-positive was greater than 50%,
participants were imputed to be retinopathy-positive; if not, they
were imputed as being retinopathy-negative. Papilledema was
considered an important covariate for the calculation of propen-
sity score but its determination by an ophthalmologist (consid-
ered the gold standard) was missing in a significant number of
children. We therefore performed analyses both with papilledema
(to account for the variable) and without it (to maximize study
power) included in the calculation of propensity score. Other
missing data were handled by listwise deletion. In all analyses,
a p value,0.05 was considered statistically significant. A detailed
description of the statistical methods used in our analyses may be
found in appendix e-1 at Neurology.org.
RESULTS Characteristics of the patients and balance
before and after propensity score matching. A total of
2,278 comatose patients were admitted to the
research ward between January 1997 and June
2013. Of these, 451 children were excluded: 442
had missing data on one or more covariates used in
the calculation of propensity score (after retinopathy
status imputation); 9 had missing data on LP perfor-
mance (figure 1). Mortality rates in participants
included in our analyses were not different, compared
to those excluded due to missing covariates (p5 0.34
for 12-hour mortality and 0.50 for mortality during
hospitalization). In the analysis omitting papilledema
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from the calculation of propensity score, 1,827
patients were included: 1,470 (80.5%) of these
patients received an LP and 357 (19.5%) did not.
In the analysis that included papilledema, 1,075
patients were included, of whom 866 (80.6%) had
an LP and 209 (19.4%) did not. Propensity scores of
children who did and did not undergo LP overlapped
significantly, indicating that propensity score
matching analyses were feasible (figure 2). Forty-
one of the 866 children who underwent LP (4.7%)
had CSF pleocytosis (leukocytes .10); a bacterial
pathogen was isolated from CSF in 20 cases and
tuberculous meningitis was diagnosed in 3
patients. A total of 87.6% (942 of 1,075 children)
had malaria parasitemia; of these, 67.9% were
malarial retinopathy–positive.
Before propensity score matching, a number of
baseline characteristics were not balanced between
children who did and did not undergo LP, as indi-
cated by standardized differences greater than 0.1
(10%) in these variables15 (tables 1 and 2). In the
analysis in which papilledema was included in the
calculation of propensity score, the 1,075 matched
pairs generated had acceptable balance for all baseline
characteristics (table 1). When papilledema was
excluded from the calculation of propensity score,
the 1,827 matched pairs were balanced for all baseline
characteristics except papilledema, which in those
children with data on this covariate was more than
twice as frequent in children who did not receive an
LP than in those who did (38% vs 16%; standardized
difference 53%; table 2).
Since the presence of papilledema influenced
whether or not a child received an LP, we report
our findings from the analyses where papilledema
was included in propensity score calculation. Results
Figure 1 Study populations for propensity score–based analyses
a Compared to those included, the 451 children excluded from analysis did not differ by sex, age, or mortality rate (using
a threshold of a 10% difference as clinically meaningful). b Covariates missing (number of children and covariate): 37
malarial retinopathy, 214 respiratory distress, 67 peripheral parasite density, 27 hematocrit, 90 blood pressure, 27 heart
examination, 11 pulse, 10 glucose, 4 sex, 5 age (252 children have missing malarial retinopathy in original data, among
which retinopathy status of 215 children are imputed from a logistic regression with hematocrit, platelet count, glucose as
covariates: retinopathy status imputed as positive if predicted probability .0.5). LP 5 lumbar puncture.
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of the analyses where papilledema was not used in
propensity score calculation are presented in table
e-1. We performed separate analyses for patients sus-
pected to have CM on presentation (Table 3), as well
as those who strictly fulfilled WHO clinical criteria
(coma malaria parasitemia, no other coma etiology
evident [table e-2]), and both showed similar results.
The proportion of children who were HIV-
positive was balanced in the LP vs no LP groups after
propensity score matching: 12.2% vs 9.6% (standard-
ized difference 0.08) in the analysis including papille-
dema in propensity score calculation and 13.1% vs
12.5% (standardized difference 0.02) in the analysis
excluding papilledema.
Association of LP with mortality at 12 hours. Unad-
justed 12-hour mortality was 7.9% lower in
children who received an LP compared to those
who did not (95% confidence interval [CI] 5.2%–
10.7%, p , 0.0001; table 3). In the propensity
score–adjusted analysis, 12-hour mortality was not
significantly different in children who underwent LP
compared to those who did not (table 3). This was the
case regardless of the propensity score–based analysis
method used. The effect size was similar and insig-
nificant in all 3 statistical methods.
Association of LP with mortality during hospitalization.
Unadjusted overall mortality was 11.4% lower in
the children who received LPs compared to those
who did not (95% CI 7.4%–15.4%, p , 0.0001;
Figure 2 Distribution of propensity scores in those who did not (A) and did (B)
receive lumbar punctures
Overlap of curves demonstrates that propensity score matching analyses are feasible.
Table 1 Baseline characteristics of the children before and after propensity score matching (analysis including papilledema in the calculation
of propensity score)
Before propensity score matching
After propensity score matching (1,075 matched pairs of
LP and non-LP participants)
No LP
(n 5 209)
LP done
(n 5 866)
Standardized
difference
No LP LP done
Standardized
differenceMean SD Mean SD Mean SD Mean SD
Date of admission, mo Jan 2005 NA Jan 2004 NA 0.30a Apr 2004 NA Dec 2003 NA 0.04
Age, mo 40.0 30.7 45.6 29.7 0.12a 46.8 35.0 45.4 29.3 0.04
Female, proportion 0.52 0.50 0.53 0.50 0.01 0.48 0.50 0.51 0.50 0.07
Blantyre Coma Score 1.29 0.73 1.31 0.71 0.08 1.44 0.71 1.39 0.71 0.07
Papilledema present, proportion 0.42 0.49 0.14 0.35 0.65a 0.18 0.38 0.21 0.41 0.08
Acidotic breathing present, proportion 0.41 0.49 0.35 0.48 0.14a 0.40 0.49 0.36 0.48 0.10
Respiratory rate, breaths/min 48.6 13.9 46.1 12.9 0.19a 46.9 14.0 45.9 12.7 0.08
CVS examination normal, proportion 0.92 0.27 0.96 0.20 0.17a 0.95 0.21 0.95 0.22 0.02
Pulse within normal range for ageb 1.57 0.53 1.57 0.53 0.00 1.57 0.53 1.57 0.54 0.00
Systolic blood pressure within normal
range for agea
1.01 0.27 1.01 0.19 0.00 1.00 0.24 1.01 0.18 0.06
Weight-for-height z score 21.12 1.34 21.06 1.41 0.04 20.99 1.32 21.04 1.42 0.04
Admission glucose, mmol/L 6.10 3.17 6.83 4.00 0.20a 5.98 2.77 6.20 3.93 0.06
Hematocrit, % 22.2 8.24 22.6 8.19 0.16a 23.6 7.94 23.4 8.19 0.03
Retinopathy present, proportion 0.74 0.44 0.60 0.49 0.21a 0.64 0.48 0.62 0.49 0.03
Parasite count per mL, logarithm 10.3 3.41 9.02 4.40 0.32a 9.39 3.96 9.19 4.27 0.05
Abbreviations: CVS 5 cardiovascular system; LP 5 lumbar puncture.
aCharacteristics where the standardized difference is greater than 0.1 (10%).
b0 5 Below reference range, 1 5 within reference range, 2 5 above reference range.
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table 3). After adjustment for propensity score, chil-
dren who did and did not receive LPs had similar
mortality rates (table 3). The effect size was similar
in all 3 statistical methods. For children with WHO
clinically defined CM, there was no significant differ-
ence in adjusted overall mortality rates for those
who underwent LP, compared to those who did not
(table e-2).
Influence of papilledema on mortality after LP.To deter-
mine whether the presence of papilledema changed
the association of LP with mortality, we assessed in-
teractions between papilledema and LP in our inverse
probability–weighted regression analyses. In the
model where outcome was mortality at 12 hours, the
effect of LP on mortality was not different when
comparing children with or without papilledema
(difference in treatment effect 5.9%, 95% CI21.4%
to 13.2%, p 5 0.12). Similar results were obtained
for overall mortality (difference in treatment effect
8.8%, 95% CI 22.5% to 20.2%, p 5 0.13), indi-
cating no effect modification by papilledema.
Association of LP with mortality in children with severely
increased brain volume on MRI. A total of 166 children
underwent brain MRI scans after LP performance.
Three children died within 12 hours of admission:
1 had an LP and the other 2 did not. Overall mortal-
ity of children who underwent MRI was 12.7%
(n 5 21).
When restricting our subanalysis to the 101 chil-
dren who had severe brain swelling with loss of brain
sulci and cisterns, with or without evidence of herni-
ation, mortality during hospitalization was 17.1%
lower in the children who received an LP compared
to those who did not (95% CI 21.4% to 35.6%,
p 5 0.07, inverse probability weighting). Mortality
within 12 hours was lower in children who under-
went LP by 6.3% (95% CI 21.9% to 14.5%, p 5
0.13). To maximize the power of this subanalysis, we
did not use papilledema in the calculation of propen-
sity score.
DISCUSSION In this large single-center study of
comatose African children without overt
meningismus but with suspected CM, we found no
evidence that those undergoing LP were at
increased risk of death. This was true even in
a subanalysis of children with MRI evidence of
severe brain swelling, several of whom had early
evidence of herniation. While both papilledema and
Table 2 Baseline characteristics of the children before and after propensity scorematching (analysis excluding papilledema in the calculation
of propensity score)
Before propensity score matching
After propensity score matching (1,827 matched pairs
of LP and non-LP participants)
No LP
(n 5 357)
LP done
(n 5 1,470)
Standardized
difference
No LP LP done
Standardized
differenceMean SD Mean SD Mean SD Mean SD
Date of admission, mo Nov 2003 NA Feb 2003 NA 0.08 Nov 2003 NA Feb 2003 NA 0.08
Age, mo 41.4 28.7 44.7 29.0 0.12a 43.1 28.8 44.5 28.7 0.05
Female, proportion 0.55 0.50 0.53 0.50 0.02 0.55 0.50 0.54 0.50 0.02
Blantyre Coma Score 1.21 0.75 1.31 0.71 0.13a 1.31 0.72 1.29 0.72 0.02
Papilledema present, proportion 0.42 0.49 0.14 0.35 0.65a 0.38 0.49 0.16 0.36 0.53a
Acidotic breathing, proportion present 0.47 0.50 0.36 0.48 0.21a 0.37 0.48 0.38 0.49 0.02
Respiratory rate, breaths/min 48.9 14.7 46.1 13.1 0.20a 47.4 13.8 46.2 13.1 0.09
CVS examination normal, proportion 0.92 0.27 0.96 0.20 0.17a 0.96 0.20 0.95 0.22 0.05
Pulse within normal range for ageb 1.57 0.53 1.56 0.53 0.01 1.54 0.54 1.56 0.53 0.02
Systolic blood pressure within normal
range for ageb
1.00 0.27 1.03 0.22 0.12a 1.04 0.27 1.03 0.22 0.06
Weight-for-height z score 21.01 1.33 21.03 1.41 0.02 20.92 1.29 21.05 1.41 0.09
Admission glucose, mmol/L 6.14 3.89 6.72 3.96 0.15a 6.76 4.17 6.64 3.87 0.03
Hematocrit, % 22.3 8.32 23.8 8.08 0.19a 23.8 8.41 23.4 8.12 0.05
Retinopathy present, proportion 0.75 0.43 0.60 0.49 0.33a 0.63 0.48 0.63 0.48 0.01
Parasite count per mL, logarithm 10.2 3.26 9.21 4.26 0.27a 9.91 3.40 9.84 4.12 0.02
Abbreviations: CVS 5 cardiovascular system; LP 5 lumbar puncture.
aCharacteristics where the standardized difference is greater than 0.1 (10%).
b0 5 Below reference range, 1 5 within reference range, 2 5 above reference range.
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brain swelling on MRI are independently associated
with fatal outcome in CM,4,16 in children lacking
lateralizing signs and judged to be stable enough to
tolerate LP by the admitting clinician, undergoing LP
did not change mortality risk in patients with these
abnormalities.
The independent association of LP and death in
CM or other CNS infections that diffusely raise
ICP has not been studied.7 Case series of patients
with meningitis5 and CM17 have described temporal
associations between LP and death, but fatal hernia-
tion in the absence of LP is recognized in both con-
ditions.5,7 Since these case series included few patients
with diffuse brain swelling who did not undergo LP,
they were unable to assess the independent associa-
tion between LP and outcome. By contrast, our
cohort included large groups of children with diffuse
brain swelling who did and did not undergo LP,
allowing us to test the independent effect of LP on
outcome using propensity-score matching. Mortality
rates were high in both those who underwent LP and
those who did not. We found no evidence that under-
going LP independently increased the risk of death.
These findings are in keeping with experiments
investigating CSF dynamics in human cadavers where
rapid equilibration between intraspinal and intracra-
nial compartments was seen when LP was per-
formed.17 Failure of equilibration and herniation
occurred only when free CSF movement was ob-
structed. We surmise that LP does not exacerbate
herniation in CM because, during LP, the CSF pres-
sure is able to rapidly equilibrate. It is important to
note that this may not be the case in patients with
raised ICP of different etiologies (e.g., space-
occupying lesion), which may impair the free move-
ment of CSF.
CM is the most common cause of encephalopathy
in sub-Saharan Africa and is therefore a differential
diagnosis in a high proportion of children with sus-
pected brain infection. If clinicians are concerned that
LP is not safe in this clinical scenario, LPs are likely to
be omitted. Omission of LPs leads to empirical anti-
malarial and antibiotic administration with subopti-
mal management through both undertreatment and
overtreatment. Frequently, children with suspected
CM recover within 24 hours of initiating treatment.
If both antibiotics and antimalarials are given and
an LP has not been performed, the underlying etiol-
ogy (meningitis, CM, or both) is difficult to determine.
Performing an LP after recovery of consciousness and
partial treatment is suboptimal because in malaria-
endemic settings, molecular diagnostics are rarely avail-
able. If an LP is not done at admission, one clinical
option is to provide the full course of antibiotic and
antimalarial treatment to all children, resulting in many
children receiving unnecessary IV drugs, experiencing
longer hospital stays, and placing strain on highly lim-
ited resources. Alternatively, clinicians could stop med-
ications and discharge the patient, risking incomplete
treatment. Epidemiologically, omitting LPs obscures
Table 3 Comparison of mortality rates before and after propensity score matching when papilledema was
used in the calculation of propensity score
No LP LP
Treatment
effecta 95% CI p Value
Before adjusting for confounding variables
No. 431 1,838b
12-Hour mortality, n (%) 59 (13.7) 107 (5.8) 7.9 5.2 to 10.7 ,0.0001
Mortality during hospitalization, n (%) 115 (26.7) 281 (15.3) 11.4 7.4 to 15.4 ,0.0001
After adjusting for confounding variables
No. 209 866
Inverse probability weighting, % 7.1 5.1 2.0 21.5 to 5.5 0.268
Logistic regression, %c 7.9 5.3 2.6 20.8 to 6.0 0.132
Matching, % 7.1 5.0 2.1 22.1 to 6.2 0.329
Mortality during hospitalization
Inverse probability weighting, % 16.8 15.1 1.7 24.5 to 7.9 0.595
Logistic regression, %c 16.9 15.3 1.6 24.0 to 7.3 0.572
Matching, % 16.9 15.2 1.7 25.0 to 8.4 0.625
Abbreviations: CI 5 confidence interval; LP 5 lumbar puncture.
a Percentage reduction in mortality in those who underwent LP compared to those who did not.
b Eight participants had missing values on 12-hour outcome because we could not confirm the exact time that LP was
performed. These participants were included in the mortality during hospitalization analysis.
c The point estimate for treatment effect was determined by logistic regression and the corresponding CI was obtained by
bootstrap.
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recognition of changes in prevalence of relevant patho-
gens. On a population level, the cumulative effects of
these suboptimal situations are substantial.
Though retrospective, our study has several
strengths. We included data collected over 16 years,
achieving a sample size that would have been difficult
to accrue in a prospective trial. We included fundu-
scopic examinations performed by ophthalmologists
and MRI scans interpreted by neuroradiologists, cre-
ating an extensive dataset including children with
objective signs of increased ICP.
This study has several limitations. We did not
assess the impact of LP on neurologic morbidity in
survivors. It is possible that LP caused neurologic
impairment but did not lead to death, although it is
difficult to think of a mechanism whereby this would
systematically occur. Although propensity score
matching is a powerful and widely used method for
reducing bias in observational studies, it has statistical
limitations, as do all analytical techniques.18 Because
the parent study focused on CM pathogenesis, the
majority of patients included in our study had CM.
Children with meningismus and a visibly cloudy CSF
were included in a separate study on meningitis;
because they lacked comparable follow-up data and
key covariates for propensity score matching, they
were not included in this analysis. The 4.7% rate of
CSF pleocytosis in our cohort is likely an underesti-
mate of the true frequency of concurrent meningitis
in children with suspected CM.
Given that increased brain volume is on the causal
pathway to death in children with CM,4 children with
this condition are a useful group in whom to assess the
longstanding controversy as to whether LP has any
causal role in fatal herniation in the context of diffusely
increased ICP. Our data provide evidence that it does
not. Although it remains to be determined whether our
findings are generalizable to meningitis or other con-
ditions that cause diffusely raised ICP, they challenge 2
of the common rationales for eschewing LPs in coma-
tose children: that the temporal association between LP
and death implies causation and that LP contributes to
mortality in children with CM who have increased
ICP. Mortality rates were high in children shortly after
admission, whether or not they underwent LP. Among
patients with objective evidence of increased ICP, LP
had no independent association with mortality.
In the clinical scenario of children with suspected
CM who are medically stable and lack localizing neu-
rologic signs, our findings provide reassurance to
clinicians that they may safely use this important
diagnostic tool.
EDITOR’S NOTE Please see the Editor’s Blog about
this article on our special interest site, Without Bor-
ders, at wb.neurology.org.
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